Hepatic drug-metabolizing enzymes and drug transporters in Wilson’s disease patients with liver failure

BACKGROUND: Wilson’s disease is a genetic disorder inherited in a recessive manner, caused by mutations in the copper-transporter ATP7B. Although it is a well-known disease, currently available treatments are far from satisfactory and their efficacy varies in individual patients. Due to the lack of...

Descripción completa

Detalles Bibliográficos
Autores principales: Szeląg-Pieniek, Sylwia, Oswald, Stefan, Post, Mariola, Łapczuk-Romańska, Joanna, Droździk, Marek, Kurzawski, Mateusz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8460590/
https://www.ncbi.nlm.nih.gov/pubmed/34117631
http://dx.doi.org/10.1007/s43440-021-00290-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8460590/
https://www.ncbi.nlm.nih.gov/pubmed/34117631
http://dx.doi.org/10.1007/s43440-021-00290-8

Ejemplares similares